Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Synspira Therapeutics Receives Orphan Designation for SNSP113 for the Treatment of Cystic Fibrosis in the European Union

firstwordpharmaApril 11, 2019

Tag: Synspira Therapeutics , orphan designation , cystic fibrosis

PharmaSources Customer Service